TCR2 Builds Cybersecurity Precautions into its Maryland Manufacturing Facility

Published on : Published by : Alex Keown

Not only have organizations been attacked, so have individual companies. Pfizer, BioNTech, and AstraZeneca, makers of two of the currently available COVID-19 vaccines, were attacked in 2020 by hackers. Other targets of hackers include Merck, Roche, and Dr. Reddy’s Laboratories. With the increasing concern of cyberattacks, TCR2 Therapeutics is taking steps to ensure that its planned 85,000 square foot state-of-the-art commercial cell therapy manufacturing facility in Rockville is as protected as possible.

Meet Your 2021 BioBuzz Award Winners

Orange banner with photos of people, with text saying "2nd Annual BioBuzz Awards - Presenting Your Winners"
Published on : Published by : BioBuzz Media

Today, we are excited to announce the winners of our 2nd Annual BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C.

2021 BioBuzz Awards Finalists

Published on : Published by : BioBuzz Media

We’re excited to announce this year’s finalists for the second annual 2021 BioBuzz Awards. These awards celebrate the people and companies across our regional community and their efforts and accomplishments to impact human health and build a stronger biotech community.

Seven Public Cell Therapy Companies Delivering Opportunities for Investors and Patients

Published on : Published by : Alex Keown

Cell therapies have grown to become a prevailing field dominating new medical breakthroughs with the promise of treatments and cures for multiple diseases. The biopharma hubs of Philadelphia and Maryland have emerged as important drivers of this new wave of medicine, build on the foundation of renowned research institutes, universities, and a number of successful cell therapy companies who have paved the way forward in this field.

Strengthening Workforce Preparedness and Diversity through Academia-Industry Partnership

Published on : Published by : Nivedita Uday Hegdekar, Ph.D.

The BioHealth Capital Region (BHCR) has been witnessing a strong upward growth trajectory in recent years. The COVID-19 pandemic has only heightened the need for increased research, diagnostic and domestic manufacturing needs in the region. But while workforce needs are in demand, the right skills are in short supply.

TCR² Therapeutics Establishing 85,000 Square Foot Cell Therapy Manufacturing Facility in Maryland

Published on : Published by : BioBuzz Media

TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. (NYSE: ARE) for an existing 85,000 square foot cell therapy manufacturing facility in Rockville, Maryland.